Yong‐Ching Yang

BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90

Karen Lundgren, Hong Zhang, John Brekken et al. · Molecular Cancer Therapeutics · 2009 · 168 citations · Full text

BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance

Hong Zhang, Laura Neely, Karen Lundgren et al. · International Journal of Cancer · 2009 · 72 citations

Pathology, Multidrug Resistance, Pharmacotherapy +17

Orally Active Purine-Based Inhibitors of the Heat Shock Protein 90

Marco A. Biamonte, Jiandong Shi, Kevin Hong et al. · Journal of Medicinal Chemistry · 2005 · 72 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +12

Identification of new biomarkers for clinical trials of Hsp90 inhibitors

Hong Zhang, Daun Chung, Yong‐Ching Yang et al. · Molecular Cancer Therapeutics · 2006 · 61 citations

Immunology, Pathology, New Biomarkers +20

Dimeric ansamycins—A new class of antitumor Hsp90 modulators with prolonged inhibitory activity

Hong Zhang, Yong‐Ching Yang, Lin Zhang et al. · International Journal of Cancer · 2006 · 18 citations

Drug Target, Apoptosis, Cell Death +18